| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 48.87B | 84.85B | 50.98B | 50.09B | 58.27B | 40.01B |
| Gross Profit | 48.87B | 75.65B | 47.08B | 48.80B | 56.48B | 38.92B |
| EBITDA | 9.86B | 24.70B | 12.33B | 11.20B | 10.02B | 12.74B |
| Net Income | 7.12B | 17.45B | 6.81B | 7.29B | 5.55B | 7.95B |
Balance Sheet | ||||||
| Total Assets | 3.46T | 3.51T | 3.38T | 3.31T | 3.32T | 3.63T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 299.37B | 178.83B | 217.36B | 411.09B | 643.72B |
| Total Debt | 188.11B | 229.29B | 182.87B | 66.57B | 8.36B | 294.66B |
| Total Liabilities | 3.30T | 3.32T | 3.21T | 3.14T | 3.17T | 3.48T |
| Stockholders Equity | 165.62B | 190.96B | 160.07B | 168.09B | 149.82B | 154.48B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 20.45B | 41.29B | 25.64B | -364.04B | 0.00 |
| Operating Cash Flow | 0.00 | 21.94B | 42.36B | 26.64B | -362.23B | 0.00 |
| Investing Cash Flow | 0.00 | 20.83B | -132.58B | -95.86B | 131.79B | 9.90B |
| Financing Cash Flow | 0.00 | 74.46B | 52.88B | -54.44B | -1.86B | 165.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥77.52B | 6.81 | ― | 2.34% | 3.68% | 26.06% | |
71 Outperform | ¥116.16B | 5.37 | ― | 3.05% | 49.84% | 156.03% | |
71 Outperform | ¥266.40B | 14.34 | ― | 2.53% | 16.63% | 19.98% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥943.92B | 11.15 | ― | 2.10% | 8.96% | 42.70% | |
64 Neutral | ¥110.42B | 23.87 | ― | 2.46% | 16.88% | 59.34% | |
60 Neutral | ¥13.07B | 27.72 | ― | 2.74% | 17.43% | -35.15% |